Diagnostics

U.K. NHS Strategic Health Authority to adopt ThinPrep Pap Test

Published in Biotech Business Week, January 10th, 2005

Cytyc Corp. (CYTC) reported that the Strategic Health Authority (SHA) of the National Health Service (NHS), covering Norfolk, Suffolk, and Cambridge, United Kingdom (U.K.), intends to convert all cervical screening to the ThinPrep Pap Test in all eight of its laboratories.

There are currently 174,000 tests processed in the Norfolk, Suffolk, and Cambridge SHA each year. This exclusive arrangement represents a potential use of approximately 800,000 ThinPrep Pap Tests over the next 5 years.

The Norfolk, Suffolk, and Cambridge Strategic Health Authority's executive team considered the National Institute for Clinical Excellence Guidance recommending...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2005-01-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry